EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Non-HACEK gram-negative bacilli infective endocarditis: data from a retrospective German cohort study

Juliane Dörfler, Herko Grubitzsch, Matthias Schneider-Reigbert, Miralem Pasic, Frieder Pfäfflin, Miriam Stegemann, Leif E Sander, Florian Kurth, Tilman Lingscheid

Infection · 2025

DOI: 10.1007/s15010-024-02392-w ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Infection, 2025. Verfasst von Juliane Dörfler und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universitä…. Hauptthemen laut MEDLINE: Endocarditis, Cross Infection, Escherichia coli Infections, Klebsiella Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charité - Universitätsmedizin Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Infective endocarditis caused by non-HACEK gram-negative bacilli (GNB-IE) is rare but associated with significant morbidity and case fatality. Evidence on optimal treatment and management is limited. We aimed to describe the characteristics and management of GNB-IE patients, investigating factors associated with disease acquisition and unfavorable outcomes.

Methods

We conducted a retrospective descriptive single-center study (tertiary care and referral hospital) between 2015 and 2021, including adult patients with definite GNB-IE. We reviewed demographic, clinical and microbiological data, focusing on predisposing factors, clinical outcomes and 1-year mortality.

Results

Of 1093 patients with probable or definite IE, 19 patients (median age 69 years) had definite GNB-IE, with an increasing incidence throughout the study period. Median age-adjusted Charlson Comorbidity Index score was 4 points. Prosthetic valve IE (PVIE) was present in 7/19 (37%) patients. Nosocomial acquisition occurred in 8/19 (42%) patients. Escherichia coli and Klebsiella pneumoniae were the most common pathogens. Beta-lactam (BL) based combination therapy was applied in 12/19 (63%) patients (58% BL + fluoroquinolone, 42% BL + aminoglycoside). Cardiac surgery was required in 8/19 (42%) patients (PVIE 71%, native valve IE 25%), primarily for embolism prevention and heart failure. Complications occurred in 14/19 (74%) patients. The in-hospital mortality rate was 21% (4/19); the one-year mortality rate was 44% (7/16). One-year mortality did not significantly differ between patients who underwent cardiac surgery and patients managed with anti-infective treatment alone ( p = 0.633).

Conclusions

GNB-IE affects elderly patients with high comorbidity levels and recent health-care exposure. GNB-IE was associated with high complication rates and high mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocarditisCross InfectionEscherichia coli InfectionsKlebsiella InfectionsHumansMaleFemaleAgedEscherichia coliKlebsiella pneumoniaebeta-LactamsGermany

Stichwörter der Autor:innen

Cardiac surgeryCombination antibiotic therapyEchocardiographyEndocarditis teamEndoplastitisEnterobacterales

Substanzen

beta-Lactams

Autor:innen und Institutionen

  • Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 1…
  • Deutsches Herzzentrum der Charité - Klinik für Herz-, Thorax- und Gefäßchirurgie, (Department of Cardiothoracic and Vascular Surgery), Augustenburger Platz 1, 13353, Berlin, Germany.
  • Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
  • Deutsches Herzzentrum der Charité - Klinik für Kardiologie, Angiologie und Intensivmedizin (Department of Cardiology, Angiology and Intensive Care Medicine), Augustenburger Platz 1, 13353, Berlin, Germany.
  • DZHK (German Center for Cardiovascular Research) Partner Site Berlin, Berlin, Germany.
  • German Center for Lung Research, DZL, Berlin, Germany.

Förderung

  • Charité - Universitätsmedizin Berlin

Zitieren

APA

Dörfler, J., Grubitzsch, H., Schneider-Reigbert, M., Pasic, M., Pfäfflin, F., Stegemann, M., Sander, L. E., Kurth, F., & Lingscheid, T. (2025). Non-HACEK gram-negative bacilli infective endocarditis: data from a retrospective German cohort study. Infection. https://doi.org/10.1007/s15010-024-02392-w

Vancouver

Dörfler J, Grubitzsch H, Schneider-Reigbert M, Pasic M, Pfäfflin F, Stegemann M, et al. Non-HACEK gram-negative bacilli infective endocarditis: data from a retrospective German cohort study. Infection. 2025. doi:10.1007/s15010-024-02392-w

BibTeX
@article{Drfler2025,
  author = {Dörfler, Juliane and Grubitzsch, Herko and Schneider-Reigbert, Matthias and Pasic, Miralem and Pfäfflin, Frieder and Stegemann, Miriam and Sander, Leif E and Kurth, Florian and Lingscheid, Tilman},
  title = {Non-HACEK gram-negative bacilli infective endocarditis: data from a retrospective German cohort study},
  journal = {Infection},
  year = {2025},
  doi = {10.1007/s15010-024-02392-w}
}
Kostenlos starten →